Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison

By  

MYCOSES (ELECTRONIC), Vol. 61, Iss. 3, 2018-03 ,pp. : 206-212

John Wiley & Sons Inc

Access to resources Recommend Favorite

High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis

By Chen Hua   Suda Katie J.   Turpin Robin S.   Pai Manjunath P.   Bearden David T.   Garey Kevin W.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1057-1065

Informa Healthcare

Access to resources Recommend Favorite

Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 6, 2015-06 ,pp. : 362-367

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off

By Findley Leslie J   Lees Andrew   Apajasalo Marjo   Pitkänen Anna   Turunen Heidi  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1005-1014

Informa Healthcare

Access to resources Recommend Favorite

Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney

By Grima Daniel T.   Airia Parisa   Attard Cheryl   Hutchison Colin A.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 383-391

Informa Healthcare

Access to resources Recommend Favorite